Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (21-30 of 206) with videos related to

Pageof 21
Sort By:
Expert Opinion on Biological Therapy|March 6, 2014
Panitumumab : leading to better overall survival in metastatic colorectal cancer?Ana Sebio, Sebastian Stintzing, Stefan Stremitzer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2017
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomesSebastian Stintzing, Sabine Tejpar, Peter Gibbs, et al.
ESMO Open|May 28, 2020
ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancerLoredana Vecchione, Sebastian Stintzing, George Pentheroudakis, et al.
Cancer Treatment Reviews|May 20, 2021
Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backboneBengt Glimelius, Sebastian Stintzing, John Marshall, et al.
Virchows Archiv : an International Journal of Pathology|June 27, 2009
Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosisSebastian Stintzing, Matthias Ocker, Andrea Hartner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2016
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trialsJulian Walter Holch, Ingrid Ricard, Sebastian Stintzing, et al.
Journal of Biomedicine & Biotechnology|June 2, 2011
Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?Sebastian Stintzing, Ralf Kemmerling, Tobias Kiesslich, et al.
Deutsches Arzteblatt International|May 28, 2009
The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR statusSebastian Stintzing, Volker Heinemann, Nicolas Moosmann, et al.
Histology and Histopathology|April 8, 2011
Role of cannabinoid receptors and RAGE in inflammatory bowel diseaseSebastian Stintzing, Till Th Wissniowski, Christina Lohwasser, et al.
Cancer Research and Treatment|April 16, 2018
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver MetastasesSebastian Stintzing, Jobst von Einem, Christoph Fueweger, et al.
Pageof 21

Showing results (21-30 of 206) with videos related to

Sort By:
Pageof 21
Expert Opinion on Biological Therapy|March 6, 2014
Panitumumab : leading to better overall survival in metastatic colorectal cancer?Ana Sebio, Sebastian Stintzing, Stefan Stremitzer, et al.
European Journal of Cancer (Oxford, England : 1990)|August 9, 2017
Understanding the role of primary tumour localisation in colorectal cancer treatment and outcomesSebastian Stintzing, Sabine Tejpar, Peter Gibbs, et al.
ESMO Open|May 28, 2020
ESMO management and treatment adapted recommendations in the COVID-19 era: colorectal cancerLoredana Vecchione, Sebastian Stintzing, George Pentheroudakis, et al.
Cancer Treatment Reviews|May 20, 2021
Metastatic colorectal cancer: Advances in the folate-fluoropyrimidine chemotherapy backboneBengt Glimelius, Sebastian Stintzing, John Marshall, et al.
Virchows Archiv : an International Journal of Pathology|June 27, 2009
Differentiation patterning of vascular smooth muscle cells (VSMC) in atherosclerosisSebastian Stintzing, Matthias Ocker, Andrea Hartner, et al.
European Journal of Cancer (Oxford, England : 1990)|December 2, 2016
The relevance of primary tumour location in patients with metastatic colorectal cancer: A meta-analysis of first-line clinical trialsJulian Walter Holch, Ingrid Ricard, Sebastian Stintzing, et al.
Journal of Biomedicine & Biotechnology|June 2, 2011
Myelodysplastic syndrome and histone deacetylase inhibitors: "to be or not to be acetylated"?Sebastian Stintzing, Ralf Kemmerling, Tobias Kiesslich, et al.
Deutsches Arzteblatt International|May 28, 2009
The treatment of colorectal carcinoma with monoclonal antibodies: the importance of KRAS mutation analysis and EGFR statusSebastian Stintzing, Volker Heinemann, Nicolas Moosmann, et al.
Histology and Histopathology|April 8, 2011
Role of cannabinoid receptors and RAGE in inflammatory bowel diseaseSebastian Stintzing, Till Th Wissniowski, Christina Lohwasser, et al.
Cancer Research and Treatment|April 16, 2018
Long-term Survival in Patients Treated with a Robotic Radiosurgical Device for Liver MetastasesSebastian Stintzing, Jobst von Einem, Christoph Fueweger, et al.
Pageof 21